Westfield Capital Management
LEGN icon

Westfield Capital Management’s Legend Biotech LEGN Stock Holding History

Westfield Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$128M Sell
4,430,063
-1,333,412
-23% -$36M 0.42% 65
2026
Q1 		$104M Sell
5,763,475
-401,202
-7% -$7.65M 0.44% 67
2025
Q4 		$134M Buy
6,164,677
+70,191
+1% +$2.01M 0.56% 43
2025
Q3 		$199M Sell
6,094,486
-378,061
-6% -$14M 0.83% 25
2025
Q2 		$230M Sell
6,472,547
-445,020
-6% -$14.4M 0.96% 20
2025
Q1 		$235M Buy
6,917,567
+1,203,871
+21% +$43.2M 1.14% 15
2024
Q4 		$186M Buy
5,713,696
+675,191
+13% +$28M 0.81% 22
2024
Q3 		$246M Buy
5,038,505
+266,296
+6% +$14.2M 1.11% 14
2024
Q2 		$211M Buy
4,772,209
+2,532,435
+113% +$117M 1.04% 15
2024
Q1 		$126M Buy
2,239,774
+463,527
+26% +$28M 0.66% 32
2023
Q4 		$107M Buy
1,776,247
+108,097
+6% +$6.85M 0.62% 38
2023
Q3 		$112M Buy
1,668,150
+696,096
+72% +$48.3M 0.76% 34
2023
Q2 		$67.1M Buy
+972,054
New +$63.5M 0.43% 92

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Westfield Capital Management's LEGN Position: Q2 2026 in Review

Westfield Capital Management reduced its Legend Biotech (LEGN) stake by 23% in Q2 2026, selling an estimated $36M and leaving 4,430,063 shares worth $128M. The position accounts for 0.42% of the portfolio, ranked #65.

Westfield Capital Management first reported a position in LEGN in Q2 2023 and has held it in 13 quarters since. The position peaked at $246M in Q3 2024. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Westfield Capital Management held 4,430,063 shares of Legend Biotech worth $128M as of Q2 2026.
  • Westfield Capital Management sold 1,333,412 Legend Biotech shares in Q2 2026, an estimated $36M.
  • Legend Biotech made up 0.42% of Westfield Capital Management's portfolio in Q2 2026, its #65 holding.
  • Westfield Capital Management first reported a position in Legend Biotech in Q2 2023 and has held it in 13 quarters since.
  • Westfield Capital Management's Legend Biotech position peaked at $246M in Q3 2024.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Westfield Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.